APA (7th ed.) Citation

Hanada, T., Kimura, F., Kitazawa, J., Morimune, A., & Murakami, T. (2021). Impact of an oral gonadotropin‐releasing hormone antagonist on severe ovarian hyperstimulation syndrome in a patient with breast cancer who received a sustained‐release gonadotropin‐releasing hormone agonist: A case report. The journal of obstetrics and gynaecology research, 47(12), 4472-4477. https://doi.org/10.1111/jog.15059

Chicago Style (17th ed.) Citation

Hanada, Tetsuro, Fuminori Kimura, Jun Kitazawa, Aina Morimune, and Takashi Murakami. "Impact of an Oral Gonadotropin‐releasing Hormone Antagonist on Severe Ovarian Hyperstimulation Syndrome in a Patient with Breast Cancer Who Received a Sustained‐release Gonadotropin‐releasing Hormone Agonist: A Case Report." The Journal of Obstetrics and Gynaecology Research 47, no. 12 (2021): 4472-4477. https://doi.org/10.1111/jog.15059.

MLA (9th ed.) Citation

Hanada, Tetsuro, et al. "Impact of an Oral Gonadotropin‐releasing Hormone Antagonist on Severe Ovarian Hyperstimulation Syndrome in a Patient with Breast Cancer Who Received a Sustained‐release Gonadotropin‐releasing Hormone Agonist: A Case Report." The Journal of Obstetrics and Gynaecology Research, vol. 47, no. 12, 2021, pp. 4472-4477, https://doi.org/10.1111/jog.15059.